Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation

American Journal of Pathology

Volumn 158, Issue 2, 2001, Pages 373-379

  Miyasaka, T ^a,b   Morishima Kawashima, M ^a   Ravid, R ^c   Heutink, P ^d   Van Swieten, J C ^d   Nagashima, K ^b   Ihara, Y ^a,e  

^a UNIVERSITY OF TOKYO   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c NETHERLANDS BRAIN BANK   (Netherlands)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; TAU PROTEIN;

ARTICLE; BRAIN DISEASE; CHROMOSOME 17; DEMENTIA; FRONTAL CORTEX; GENE MUTATION; GENETIC LINKAGE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PARKINSONISM; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035131614     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63979-X     Document Type: Article

References (26)

1. Tau is a candidate gene for chromosome 17 frontotemporal dementia
2. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
3. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
4. Untangling tau-related dementia
5. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly
6. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17
7. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements
8. Expression of separate isoforms of human tau protein: Correlation with the tau pattern in brain and effects on tubulin polymerization
9. Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments
10. Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation
11. Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)
12. The FTDP-17-linked mutation R406W abolishes the interaction of phosphorylated tau with microtubules
13. Phenotypic variation in hereditary frontotemporal dementia with tau mutations
14. Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau
15. The Global Deterioration Scale for assessment of primary degenerative dementia
16. The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia ("pallido-ponto-nigral degeneration")
17. Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain
18. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis
19. Deamidation and isoaspartate formation in smeared tau in paired helical filaments. Unusual properties of the microtubule-binding domain of tau
20. Characterization of two distinct monoclonal antibodies to paired helical filaments: Further evidence for fetal-type phosphorylation of the tau in paired helical filaments
21. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404
22. Proline-directed and non-proline-directed phosphorylation of PHF-tau
23. Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments
24. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids
25. Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue
26. Lack of the carboxyl terminal sequence of tau in ghost tangles of Alzheimer's disease